Antibodies were raised against two synthetic peptides whose sequences correspond respectively to the COOH-terminal end (residues 501-516) of the protein encoded by the gene for the 8 chain and to a proposed cytoplasmic region (residues 350-358) of the (3 chain of the acetylcholine receptor from Torpedo californica. Binding of the COOHterminal antibody to the acetylcholine receptor in intact, receptor-rich vesicles was tested by radioimmunoassay and by precipitation with immobilized protein A. In both cases, binding was detected only after treatment of the vesicles with detergent, suggesting that the segment of the receptor that is recognized by this antibody is on the cytoplasmic side of the membrane. Electron microscopy of tissue from Torpedo electric organ labeled with colloidal gold-conjugated second antibodies established that both anti-receptor antibodies bind to the cytoplasmic surface of the postsynaptic membrane. These experiments give ultrastructural evidence that the COOH-terminal segment of the 8 chain as well as residues 350-358 of the (3 chain are on the cytoplasmic surface. They strongly support a model in which each of the receptor subunits crosses the membrane five times and in which one transmembrane segment of each chain contributes to the formation of a central ion channel.
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The nicotinic acetylcholine receptor (AcChoR) is located in the postsynaptic membrane of cholinergic nerve terminals at neuromuscular junctions. It forms a gated ion channel that permits passage of 104 sodium ions per msec upon agonist binding (1) (2) (3) . The receptor is a pentamer of four different subunits (a-8) with stoichiometry a2f8y8 (4) (5) (6) . All of the subunits span the membrane and occupy quasi-equivalent positions around the ion channel as seen by electron microscopy (7) . The apparent molecular weights of the mature subunits, based on NaDodSO4/PAGE, are 40,000 (a), 49,000 (,3), 60,000 (y), and 65,000 (8) (1, 2) ; based on the recently published cDNA sequences of the subunits, however, they are 53,649 (a), 56,060 (13) , 58 ,053 (y), and 59,792 (8) before glycosylation or possible proteolytic processing (8) (9) (10) (11) (12) (13) . The receptor is glycosylated approximately eight times (14) , so that the estimated total molecular weight is 295,000 (15) . The deduced amino acid sequences reveal striking homology between the different subunits (6, 13, 15) . This homology has led to the idea that each of the subunits contributes a similar peptide component to the formation of a central ion channel (3, 15) . The subject of this paper is the topology of the peptide chain within the membrane as it relates to the ion channel. Several models of peptide folding across the membrane, having either four, five, or six membrane crossings per subunit, have been suggested (10, 12, 13, (15) (16) (17) (18) . Because the NH2 terminus of 8 is in the extracellular portion of the protein (19), models with four or six membrane crossings orient both NH2-and COOH termini on the extracellular side of the membrane. Models with five membrane crossings place the COOH terminus on the cytoplasmic side. To locate the COOH terminus, we generated polyclonal antibodies against a synthetic hexadecapeptide corresponding to the COOH terminus of the 8 chain, since it has the longest hydrophilic sequence as predicted from the cDNA sequence. With these antibodies, we show (i) that the COOH terminal sequence deduced from the cDNA clone of the 8 subunit is present in the mature 8 subunit of the acetylcholine receptor and (ii) that this amino acid sequence lies on the cytoplasmic side of the membrane. We also raised antibodies to a synthetic peptide corresponding to residues 350-358t of the 8 chain to further map the topology of the receptor chains with respect to the membrane. This portion of the mature f3 chain also was localized to the cytoplasmic side of the membrane as previously suggested (10, 12, 13, 15, 16, 18, 20, 21) . There must, therefore, be an even number of transmembrane segments between residue 358 and the COOH terminus. These results are consistent with our hypothesis of a second, possibly channel-forming segment that crosses the membrane in this region.
METHODS
Anti-6 COOH Terminus Antibody (Antibody 8-273). The peptide Ac-Pro-Phe-Glu-Gly-Asp-Pro-Phe-Asp-Tyr-Ser-SerAsp-His-Pro-Arg-Gly-SH, corresponding to the sequence Ac-[GlyS516]8-subunit-(501-516) (GlyS, thioglycine) of the 517-amino acid 8 subunit, was synthesized by the solidphase method (22) , starting with tert-butyloxycarbonylthioglycine resin (23, 24) . The peptide product was purified by partition chromatography (25) on Sephadex G-50 and characterized by paper electrophoresis, high performance partition chromatography, and amino acid analysis. The peptide was selectively coupled at its COOH terminus to bovine serum albumin (BSA) by reaction with silver nitrate/N-hydroxysuccinimide (23, 24) as previously described for the coupling of corticotropinylthioglycine (26) (20) .
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Proc. NatL Acad Sci. USA 82 (1985) 627 in Freund's complete adjuvant (27) . To characterize the antiserum, a sample of the peptide was treated with silver nitrate to give Ac-[Gly56]&-subunit-(501-516), which was then radioiodinated by the chloramine-T method (27) . A sensitive radioimmunoassay capable of detecting 5-10 pg of peptide has been established by using standard procedures (27) . The antiserum was used at a final dilution of 1:20,000. Peptide bound to antibody was separated from free peptide by charcoal adsorption (28) . All three rabbits immunized showed production of antibodies against the peptide. None of the animals showed symptoms of myasthenia gravis.
Antibody Purification. IgG-rich fractions of the collected rabbit sera were obtained by precipitating the whole sera with ammonium sulfate at 30% saturation. The resulting precipitate was washed with a 35%-saturated ammonium sulfate solution and then dissolved in 20 mM phosphate buffer, pH 7.4. Buffer was adjusted to 0.15 M NaCl/20 mM phosphate, pH 7.4 (P1/NaCl) and protein was concentrated by using Amicon Centriflo membrane cones (nominal Mr retention :25,00). An affinity column was prepared by coupling the peptide to aminohexyl-Sepharose as previously described for the preparation of f3-endorphin-Sepharose (29) . Whole serum was applied to the peptide-Sepharose column at room temperature and washed with 10 column volumes of Pi/ NaCl. The retained fraction was eluted with 100 mM glycine HCl, pH 3.2, containing BSA at 1 mg/ml. Eluate fractions were neutralized immediately with a saturated Na2HPO4 solution and were concentrated by using the Centriflo cones.
Anti-. Antibody (Antibody (-350). The peptide Thr-Pro-
Ser-Pro-Asp-Ser-Lys-Pro-Thr-Cys was synthesized by Sequemat (Boston, MA). The first nine residues reproduce the sequence 350-358 of the ,3 subunit of the AcChoR. The peptide was coupled to BSA with diazotized benzidine (30) and injected intradermally into a female New Zealand White rabbit. The serum was tested as described for the anti-8 antibodies. Dilutions of 1:100 and 1:1000 were used. There were no signs of myasthenia gravis in the animal.
The antibody was affinity-purified on a column of peptidelinked CN-Sepharose (Pharmacia) and eluted with 3 M sodium thiocyanate. After extensive dialysis against P,/NaCl, the antibodies were concentrated with Aquacide III (Calbiochem).
Control Antibodies. Several antibodies were used throughout this work as controls: monoclonal antibodies (mAbs) 210, 111, and 35 (referred to as L-210, L-111, and L-35), generated in rats (31, 32) , were generously provided by J. Lindstrom (Salk Institute, La Jolla, CA). mAb 88 (referred to as F-88) which was generated in mice (33) and a rabbit polyclonal anti-Torpedo californica AcChoR serum were generously provided by S. Froehner (Dartmouth Medical School, Hanover, NH).
Immunoblots. Affinity-purified T. californica AcChoR or a 1% (wt/vol) Triton X-100 extract of tissue that had been disrupted and washed exactly as for electron microscopy was electrophoresed on a NaDodSO4/9% polyacrylamide gel. The proteins were electrophoretically transferred to a nitrocellulose filter (34) . The nitrocellulose filter was cut into strips and each strip was incubated with first antibody followed by 125I-labeled second antibody. Bands were detected by autoradiography at -70°C on Kodak X-Omat film.
Antibody Binding Assay. In vitro antibody-binding studies were done using extracellular-side-out AcChoR vesicles (35, 36) in which disulfide bonds had been reduced and carbamoylmethylated with 2-mercaptoethanol and iodoacetamide to ensure that all AcChoR was monomeric (37 er, and then mounted on a slide with a cover slip for fluQres cence microscopy. For colloidal gold labeling, samples were incubated overnight with 5 nm colloidal gold conjugate4.,'ei'-ther to goat anti-rabbit IgG or to goat anti-rat IgCG (Janssen Pharmaceutica, Beerse, Belgium) and then washed OUr times in tissue buffer. Tissue was fixed in 2% (vol/vol) gnldtaraldehyde/100 mM sodium cacodylate for 1.5 hr on ice and then washed three times in 100 mM sodium cacodylate. $tAples were post-stained with 2% (wt/vol) osmium tetrqide/100 mM sodium cacodylate at room temperature, d~y-drated in ethanol, and embedded in Epon (600C). Silvergiay sections were adsorbed to cleaned copper grids, post-staiied with 1% (wt/vol) uranyl acetate, and coated with carbhn.
Electron microscopy was carried out using an 80 kV acele'tating voltage on a Phillips EM-400 microscope.
RESULTS AND DISCUSSION
Immunoblots with either purified AcChoR or a crude membrane extract of Torpedo electric organ showed that affinitypurified antibodies 8-273 and 83-350 bind to the 8 and (3 chains, respectively, of the mature AcChoR. There was esg sentially no cross-reactivity to the other chains of AcChbR or to other proteins (Fig. 1) and d) , (-350 (lanes b and e) and a rabbit anti-Torpedo AcChoR serum (lanes c and f) were incubated with nitrocellulose blots of electrophoresed affinity-purified AcChoR (lanes a-c) or a Triton X-100 extract of electric organ prepared as for electron microscopy (lanes d-f), followed by incubation with '25I-labeled-goat anti-rabbit IgG and autoradiogra- To determine directly the sidedness of binding to the AcChoR in outside-out vesicles, we used an immunoprecipitation assay that depends on accessibility pf bound antibody to immobilized protein A. Two antibodies were used as controls: mAb L-35, which binds to the main immunogenic region on the a chain on the synaptic side of the membrane; and mAb F-88, which binds both By and 8 on the cytoplasmic side. mAb L-35 gave 100% immunoprecipitation bf the 125i-labeled receptors when incubated with either intact or detergent-treated preparations. In contrast, mAb F-88 precipitated <10% of labeled AcChoR from intact vesicles, presumably due to AcChoR in membrane sheets rather than in vesicles. More than 55% were precipitated from detergentsolubilized vesicles (Fig. 3) . The failure to achieve 100% precipitation with mAb F-88 is unexplained; higher antibody concentrations did not increase the amount of AcChoR precipitated, and the results were the same whether vesicles were solubilized before or after application of the first antibody.
The pattern obtained with anti-8 COOH-terminus antibodies (8-273) was essentially identical to that obtained with mAb F-88: precipitation of AcChoR from intact vesicles increased from 8% to 45% upon solubilization with cholate. Similar results were obtained using /3350, with precipitation of up to 26% of solubilized AcChoR. When intact but leaky vesicles were substituted for saponin-treated vesicles, up to =w50 of AcChoR could be precipitated by 8-273 or by F-88.
These results indicate that both 6-273 and /&350 recognize an internal (cytoplasmic) site on the AcChoR.
To localize the sites of binding of the antibodies to the AcChoR in tissue rather than vesicles and without recourse to detergent treatment, we examined sections of Torpedo electric organ by immuno-electron microscopy. Disrupted tissue was incubated with anti-peptide antibody followed by second antibody conjugated to colloidal gold. Basal lamina and portions of presynaptic membrane with associated synaptic vesicles were seen to adhere to the postsynaptic membrane (Fig. 4) allowing its two sides to be unambiguously identified. Both antibodies 6-273 and /&350 bound excclusively to the cytoplasmic side (Figs. 4 and 5) . The results obtained with the two antibodies, although similar, showed differences in detail. ,-350 showed a relatively uniform distri- bution of label like, that seen with mAb L-111 (Fig. 4 C and   D) , which binds to the cytoplasmic surface (32). showed a more uneven distribution, suggesting that in some regions the antigenic site may be physically or conformationally less accessible. Both sides of the membrane were accessible to anti-receptor antibodies as well as to gold-conjugated second antibodies, since labeling of the synaptic side was obtained with mAb L-210, which binds to an extracellular site on the AcChoR (Fig. 4B) (Fig. 6 ). Opitope, because the possibility of loosening the target peptide it the exterior surface, also leading to enhancement, c*Enbt be excluded. Our results are consistent with the idea that the ion channel in the AcChoR is formed by five homologous amphipathic helices, each of which contributes charged residues to the lining of a water-filled ion-conductingchannel (Fig. 7) . Model-building and energy calculations with the program AMBER (41) show that this structure can catalyze the passage of hydrated sodium ions or organic cationsj known to pass through the AcChoR channel (unpublishod 
